Literature DB >> 26826776

Self-reported smoking, serum cotinine, and blood DNA methylation.

Yan Zhang1, Ines Florath2, Kai-Uwe Saum3, Hermann Brenner4.   

Abstract

BACKGROUND: Epigenome-wide profiling of DNA methylation pattern with respect to tobacco smoking has given rise to a new measure of smoking exposure. We investigated the relationships of methylation markers with both cotinine, an established marker of internal smoking exposure, and self-reported smoking.
METHODS: Blood DNA methylation levels across the genome and serum cotinine were measured in 1000 older adults aged 50-75 years. Epigenome-wide scans were performed to identify methylation markers associated with cotinine. The inter-dose-response relationships between the number of cigarettes smoked per day, cotinine concentration, and DNA methylation were modeled by restricted cubic spline regression.
RESULTS: Of 61 CpGs that passed the genome-wide significance threshold (p<1.13×10(-7)), 40 CpGs in 25 chromosomal regions were successfully replicated, showing 0.2-3% demethylation per 10ng/ml increases in cotinine. The strongest associations were observed for several loci at AHRR, F2RL3, 2q37.1, 6p21.33, and GFI1 that were previously identified to be related to self-reported smoking. One locus at RAB34 was newly discovered. Both cotinine and methylation markers exhibited non-linear relationships with the number of cigarettes smoked per day, where the highest rates of increase in cotinine and decreases in methylation were observed at low smoking intensity (1-15 cigarettes/day) and plateaued at high smoking intensity (>15-20 cigarettes/day). A clear linear relationship was observed between cotinine concentration and methylation level. Both cotinine and methylation markers showed similar accuracy in distinguishing current from never smoker, but only methylation markers distinguished former from never smoker with high accuracy.
CONCLUSIONS: Our study corroborates and expands the list of smoking-associated DNA methylation markers. Methylation levels were linearly related to cotinine concentration and provided accurate measures for both current and past smoking exposure.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cotinine; DNA methylation; Dose-response relationship; Epigenome-wide association study; Smoking

Mesh:

Substances:

Year:  2016        PMID: 26826776     DOI: 10.1016/j.envres.2016.01.026

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  39 in total

1.  Tobacco smoking and smoking-related DNA methylation are associated with the development of frailty among older adults.

Authors:  Xu Gao; Yan Zhang; Kai-Uwe Saum; Ben Schöttker; Lutz Philipp Breitling; Hermann Brenner
Journal:  Epigenetics       Date:  2016-12-21       Impact factor: 4.528

2.  DNA methylation changes in response to active smoking exposure are associated with leukocyte telomere length among older adults.

Authors:  Xu Gao; Ute Mons; Yan Zhang; Lutz Philipp Breitling; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2016-11-10       Impact factor: 8.082

Review 3.  Epigenome-based cancer risk prediction: rationale, opportunities and challenges.

Authors:  Martin Widschwendter; Allison Jones; Iona Evans; Daniel Reisel; Joakim Dillner; Karin Sundström; Ewout W Steyerberg; Yvonne Vergouwe; Odette Wegwarth; Felix G Rebitschek; Uwe Siebert; Gaby Sroczynski; Inez D de Beaufort; Ineke Bolt; David Cibula; Michal Zikan; Line Bjørge; Nicoletta Colombo; Nadia Harbeck; Frank Dudbridge; Anne-Marie Tasse; Bartha M Knoppers; Yann Joly; Andrew E Teschendorff; Nora Pashayan
Journal:  Nat Rev Clin Oncol       Date:  2018-02-27       Impact factor: 66.675

4.  Accuracy and utility of an epigenetic biomarker for smoking in populations with varying rates of false self-report.

Authors:  Allan M Andersen; Robert A Philibert; Fredrick X Gibbons; Ronald L Simons; Jeffrey Long
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-06-14       Impact factor: 3.568

Review 5.  DNA methylation-based predictors of health: applications and statistical considerations.

Authors:  Paul D Yousefi; Matthew Suderman; Ryan Langdon; Oliver Whitehurst; George Davey Smith; Caroline L Relton
Journal:  Nat Rev Genet       Date:  2022-03-18       Impact factor: 53.242

6.  Nicotine dose-dependent epigenomic-wide DNA methylation changes in the mice with long-term electronic cigarette exposure.

Authors:  Gang Peng; Yibo Xi; Chiara Bellini; Kien Pham; Zhen W Zhuang; Qin Yan; Man Jia; Guilin Wang; Lingeng Lu; Moon-Shong Tang; Hongyu Zhao; He Wang
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

7.  Associations of self-reported smoking, cotinine levels and epigenetic smoking indicators with oxidative stress among older adults: a population-based study.

Authors:  Xu Gao; Xīn Gào; Yan Zhang; Lutz Philipp Breitling; Ben Schöttker; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2017-04-22       Impact factor: 8.082

8.  The sbv IMPROVER Systems Toxicology Computational Challenge: Identification of Human and Species-Independent Blood Response Markers as Predictors of Smoking Exposure and Cessation Status.

Authors:  Vincenzo Belcastro; Carine Poussin; Yang Xiang; Maurizio Giordano; Kumar Parijat Tripathi; Akash Boda; Stéphanie Boué; Mario Guarracino; Florian Martin; Manuel C Peitsch; Julia Hoeng; Roberto Romero; Adi L Tarca; Zhongqu Duan; Hao Yang; Xiaofeng Gong; Peixuan Wang; Chenfang Zhang; Wenxin Yang; Omer Sinan Sarac; Ismail Bilgen; Ali Tugrul Balci; Rahul Kumar; Sandeep Kumar Dhanda
Journal:  Comput Toxicol       Date:  2017-07-14

9.  The Status of Nitric Oxide and its Backup, Heme Oxygenase 1, in Thromboangiitis Obliterans.

Authors:  Ali Aliee; Farnaz Zahedi Avval; Hossein Taheri; Saeedeh Mehraban Moghadam; Mohammad Soukhtanloo; Daryoush Hamidi Alamdari; Bahare Fazeli
Journal:  Rep Biochem Mol Biol       Date:  2018-04

Review 10.  Cigarette smoke-induced alterations in blood: A review of research on DNA methylation and gene expression.

Authors:  Constanza P Silva; Helen M Kamens
Journal:  Exp Clin Psychopharmacol       Date:  2020-07-13       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.